Last reviewed · How we verify

Platelet rich plasma intrauterine infusion

Tanta University · FDA-approved active Biologic Quality 5/100

Platelet rich plasma intrauterine infusion is a Biologic drug developed by Tanta University. It is currently FDA-approved.

At a glance

Generic namePlatelet rich plasma intrauterine infusion
SponsorTanta University
ModalityBiologic
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Platelet rich plasma intrauterine infusion

What is Platelet rich plasma intrauterine infusion?

Platelet rich plasma intrauterine infusion is a Biologic drug developed by Tanta University.

Who makes Platelet rich plasma intrauterine infusion?

Platelet rich plasma intrauterine infusion is developed and marketed by Tanta University (see full Tanta University pipeline at /company/tanta-university).

What development phase is Platelet rich plasma intrauterine infusion in?

Platelet rich plasma intrauterine infusion is FDA-approved (marketed).

Related